15.2 Compounding Standards & Quality
Key Takeaways
- Quality compounding depends on accurate weighing and measuring with calibrated equipment, controlled processes, and fit-for-purpose facilities—not approximate “eyeballing”.
- Hygiene, PPE, and cleaning reduce microbial contamination and cross-contamination between products and patients.
- Batch records and documentation create an auditable trail: formula source, quantities, calculations, operator, checks, BUD, and label text.
- Labels for compounded medicines must identify the product as compounded and include critical details such as active strength, quantity, BUD, storage, and patient directions.
- Error prevention includes independent calculation checks, clear units, segregation of hazardous materials, and professional responsibility when outsourcing to another compounder.
14.2 Compounding Standards & Quality
Quick Answer: Safe compounding is a quality system, not a casual mix. Use calibrated balances and measures, follow APF methods and professional standards, maintain hygiene and segregation, complete batch/compounding records, and issue labels that clearly show the product is compounded, with strength, BUD, storage, and directions. Prevent calculation and selection errors with checks. If you outsource, you still carry professional responsibility for suitability, communication, and patient counselling.
Standard 3.4 expects pharmacists to compound medicines to a standard that protects patients. Quality failures—wrong strength, contamination, missing BUD, illegible labels—cause real harm. The Intern Written Examination tests whether you can recognise those failure modes and the controls that prevent them.
Accurate weighing, measuring, and equipment
Weighing and measuring discipline
- Use a balance appropriate to the mass being weighed (sensitivity and capacity matched to the task)
- Zero/tare correctly; protect balances from drafts, vibration, and powder spills
- Prefer weighing solids over repeated volumetric guesses when accuracy matters
- For liquids, use graduated measures appropriate to the volume; read menisci correctly; avoid household spoons for compounding stock
- Convert units carefully (mg ↔ g, % w/v, mg/mL)—unit errors are classic high-harm mistakes
Calibration and maintenance
Equipment that is not calibrated or fit for purpose undermines every later step. Community pharmacies that compound should maintain procedures for checking balances, thermometers (if used), and measuring devices, and for removing defective equipment from service. For the exam, the principle is: do not rely on unvalidated kitchen scales or damaged glassware for patient-specific medicines.
Process control
Follow a written formula and method (APF standard formula or approved worksheet):
- Gather ingredients and confirm identity, grade, and expiry of starting materials
- Perform and record calculations before dispensing materials
- Weigh/measure with a witness or systematic self-check for high-risk items
- Mix in the correct order (for example geometric dilution of potent powders; levigating agents before incorporating into bases)
- Inspect the finished product (uniformity, absence of grit, correct appearance)
- Package in suitable containers (light-resistant, child-resistant where required, appropriate for topical vs oral)
Hygiene and contamination control
Personal and environmental hygiene
- Clean work surfaces before and after compounding
- Hand hygiene and appropriate PPE (gloves, gown/coat, hair cover as risk requires; eye protection for irritants)
- Minimise unnecessary conversation and traffic over open products
- Dedicate utensils where possible; wash and dry thoroughly between products
Avoiding cross-contamination
Cross-contamination is a major quality risk—especially with:
- Potent hormones
- Antibiotics (allergy risk residues)
- Cytotoxic or hazardous powders
- Strong dyes and odorous substances
- Penicillin-class powders in environments serving allergic patients
Controls: segregation of workspace and equipment, closed containers, careful powder handling, cleaning validation mindset (documented cleaning of shared equipment), and refusing to prepare incompatible sequences without decontamination. Never prepare a product for a patient with a known severe allergy on equipment still contaminated with that allergen.
Microbial contamination of aqueous multi-dose products is reduced by clean technique, suitable preservatives when appropriate and compatible, patient counselling on hygiene of measuring devices, and realistic BUDs.
Documentation and batch records
If it is not documented, it is difficult to defend, repeat, or investigate. A compounding/batch record typically includes:
| Record element | Why it matters |
|---|---|
| Patient and prescriber identifiers | Links product to clinical authority |
| Date of preparation | Starts the BUD clock and audit trail |
| Formula reference (e.g. APF monograph / worksheet ID) | Shows method source |
| Ingredient names, batch/lot, expiry, quantities | Traceability if a recall or ADR occurs |
| Calculations | Supports independent check |
| Operator and checker identity | Accountability |
| Yield / quantity prepared | Detects major process loss or error |
| BUD and storage assigned | Critical safety information |
| Label text / version | Ensures label matches record |
| Deviations and problems | Continuous quality improvement |
Documentation is part of professional responsibility, not optional paperwork. On exam scenarios, choose options that include recording formula source, quantities, and checks—not “compound from memory and hand over”.
Labelling compounded products
Compounded medicines must be labelled so the patient, carer, and any other health professional can use them safely. Align with APF/professional labelling guidance and Poisons legislation requirements for the schedule of the medicine.
Essential label content (practical checklist)
- Patient name
- Active ingredient(s) and strength (clear units; final concentration after compounding)
- Dose form and quantity supplied
- Directions for use (and measuring device advice for liquids)
- Beyond-use date and storage conditions
- Pharmacy name/address and telephone
- Date of supply / preparation
- Prescription/reference number as required
- Explicit identification that the product is compounded (so it is not mistaken for a manufacturer’s pack)
- Relevant cautionary advisory labels (for example external use only, shake the bottle, refrigerate)
Exam emphasis: missing BUD, missing strength, or failure to mark a product as compounded are common “unsafe label” patterns. Strength must reflect the finished product (e.g. mg/mL of suspension), not only the input powder weight without vehicle.
Distinguishing from proprietary packs
Patients may assume a pharmacy-packed product has the same shelf-life as a factory blister. Counselling and label wording must correct that assumption. Keep original manufacturer packs for proprietary products; for compounds, use containers suited to the preparation and label them completely.
Error prevention
High-yield error types in compounding:
- Calculation errors (decimal place, % vs mg/mL, adult vs paediatric dose concentration)
- Ingredient selection errors (wrong salt, wrong base, look-alike stock bottles)
- Unit and device errors (mg measured as g; syringe vs cup confusion at home)
- Process errors (skipped geometric dilution → hot spots of potent drug)
- Labelling transcription errors (correct compound, wrong directions)
Defences:
- Written worksheets with blank fields that force entry of each quantity
- Independent double-check of calculations for high-risk preparations
- Read-aloud verification of stock bottle names and strengths
- Standardised units on labels
- Segregated storage of finished compounds awaiting checking
- Final clinical check: does the strength and directions match the prescription and patient age/weight?
Professional responsibility when outsourcing compounding
Not every pharmacy compounds every product. Outsourcing to a specialist compounding pharmacy or hospital service can improve quality for complex items—but outsourcing does not remove all responsibility.
Responsibilities that remain with the supplying pharmacist
- Confirm the prescription is clinically appropriate and legally valid
- Confirm compounding is necessary (no suitable proprietary product)
- Communicate complete, accurate prescription details and patient factors (allergies, age, indication)
- Ensure the patient receives counselling on use, storage, BUD, and what to do if the product looks abnormal
- Manage continuity if supply is delayed
- Report and act on quality complaints or suspected adverse events
Choose outsource partners with appropriate licences, quality systems, and transparent certificates of analysis/batch documentation where relevant. Do not “sign off” a product you know is unsuitable simply because another facility made it.
Linking quality to APF and Board expectations
The APF supports method selection, general precautions, and labelling/BUD thinking. Pharmacy Board codes and guidelines, together with state/territory legislation, frame professional obligations for premises, supervision, and safe practice. For interns:
- Work within competence and supervised scope
- Escalate when facilities or training are inadequate
- Treat every compound as a patient-specific medicine requiring the same clinical filters as dispensing
Putting it together for the exam
When a vignette describes a compounding near-miss, prioritise measurement accuracy, documentation, label completeness (strength, BUD, storage, compounded identity), contamination control, and checks. Quality is how Standard 3.4 is operationalised after the decision to compound has been justified.
Which label set best meets quality expectations for a patient-specific compounded oral suspension?
A pharmacy compounds a potent topical hormone cream then, without cleaning shared equipment, prepares an emollient for a child with highly sensitive skin. What is the principal quality risk illustrated?
Which practice best supports accurate strength in a non-sterile powder trituration of a potent drug into a bulk powder?
A community pharmacy outsources a complex non-sterile compound to a specialist facility. Which statement is correct?